Coldstream Laboratories, Inc., a Piramal Enterprises business, will be attending Bio Internatinal Convention 2015 in Philadelphia, PA. The event will take place at the Pennsylvania Convention Center June 15-18, 2015.
Coldstream and Goodwin Biotechnology will co-exhibit at the World ADC Summit in San Francisco, CA, from October 14th to 17th. Please meet us at Booth #13 to discuss your cytotoxic antibody drug conjugation needs.
LEXINGTON, KY--(Marketwired - Sep 24, 2013) - Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that they have been awarded a 5-year contract with the National Cancer Institute ("NCI") under solicitation number N02CM37007-11 (contract# HHSN261201300031I) entitled "Development and Production of Parenteral Dosage Forms for Clinical Studies."
Christopher A. Verbicky, Ph.D., MBA, will be attending the “6th Product and Pipeline Enhancement for Generics Conference” in this week in Washington, D.C. The event will take place at the Sheraton Crystal City Hotel July 23 – 25, 2013.
Plantation, Florida and Lexington, Kentucky-- Goodwin Biotechnology, Inc. (GBI) and Coldstream Laboratories, Inc. have established a collaboration for developing and manufacturing high-potency, highly cytotoxic materials (e.g., small molecules, protein toxins, cytotoxic antibody drug conjugates, and other bioconjugates).
Photo Caption: Equinext’s President and CEO, Eric Hauck, with Eric Smart, President and CEO of Coldstream Laboratories in Coldstream’s sterile manufacturing facility.
The sterile manufacturing facility at Coldstream Laboratories employs unique mobile isolator technology to allow flexibility in executing a wide variety of manufacturing processes. Our isolators facilitate handling of difficult-to-manufacture drug products and ensure the safety of our workforce throughout the production process. Mobile isolators provide an ISO Class 5 environment for aseptic processing and minimize human contact with the products we manufacture. This technology allows Coldstream to process a variety of potent drug substances such as cytotoxins in an adaptable alternative manufacturing setting when compared to standard clean rooms.